Integration of the NF-κB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: Divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts

Cytokine

Volumn 12, Issue 10, 2000, Pages 1469-1479

  Barchowsky, Aaron ^a   Frleta, Davor ^a   Vincenti, Matthew P ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Collagenase; Cytokines; Mitogen activated protein kinases; Nuclear factor kappa B; Transcription

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGENASE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; ENZYME INHIBITOR; FLAVONOID; IMIDAZOLE DERIVATIVE; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; PYRIDINE DERIVATIVE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RABBIT; RHEUMATOID ARTHRITIS; SYNOVIUM; ANIMAL; BIOSYNTHESIS; CULTURE MEDIUM; DOSE RESPONSE; ENZYME ACTIVATION; ENZYMOLOGY; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; PLASMID; PROTEIN BINDING; REPORTER GENE; SIGNAL TRANSDUCTION; TIME; TRANSACTIVATION; WESTERN BLOTTING;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; BLOTTING, WESTERN; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; FIBROBLASTS; FLAVONOIDS; GENES, REPORTER; IMIDAZOLES; INTERLEUKIN-1; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; PYRIDINES; RABBITS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033623180     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0743     Document Type: Article

References (50)

1. Interleukin-1 and tumor necrosis factor: Effector cytokines in autoimmune diseases
2. Pro-inflammatory signaling: Last pieces in the NF-kappaB puzzle?
3. Severe Liver Degeneration in Mice Lacking the IkappaB Kinase 2 Gene
4. Phosphorylation of c-jun mediated by MAP kinases
5. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate and serum
6. The mitogen-activated protein kinases, ERK1 and ERK2
7. The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif
8. Integration of MAP kinase signal transduction pathways at the serum response element
9. Regulation and function of the JNK subgroup of MAP kinases
10. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
11. Selective interaction of JNK protein kinase isoforms with transcription factors
12. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
13. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation
14. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway
15. The regulation of AP-1 activity by mitogen-activated protein kinases
16. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanisms that control enzyme activity, transcription, and mRNA stability
17. Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts
18. Defining therapeutic targets by using adenovirus: Blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators
19. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels
20. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function
21. NF-kappaB regulation by IkappaB kinase in primary fibroblast-like synoviocytes [In Process Citation]
22. Isolation of a collagenase cDNA clone and measurement of changing collagenase mRNA levels during induction in rabbit synovial fibroblasts
23. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation
24. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts
25. Rapid detection of octamer binding proteins with 'mini-extracts' prepared from a small number of cells
26. Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcriptional mechanisms
27. Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: Differential expression with collagenase-1 (matrix metalloproteinase-1)
28. The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding
29. MAP kinase is constitutively activated in gip2 and src transformed rat 1a fibroblasts
30. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways
31. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38
32. v-src activation of the collagenase-1 (matrix metalloproteinase-1) promoter through PEA3 and STAT: Requirement of extracellular signal-regulated kinases and inhibition by retinoic acid receptors
33. Interleukin 1 and tumour necrosis factor activate the mitogen-activated protein (MAP) kinase kinase in cultured cells
34. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors
35. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
36. Phorbol ester-inducible genes contain a common cis elecent recognized by a TPA-modulated trans-acting factor
37. Interleukin-1 stimulates and all-transretinoic acid inhibits collagenase gene expression through its 5' activator protein-1-binding site
38. Jun N-terminal kinase in rheumatoid arthritis
39. src-related tyrosine kinases regulate transcriptional activation of the interstitial collagenase gene, MMP-1, in interleukin-1-stimulated synovial fibroblasts
40. Two activator protein-1 elements in the matrix metalloproteinase-1 promoter have different effects on transcription and bind Jun D, c-Fos, and Fra-2
41. Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-beta in fibroblasts and keratinocytes
42. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras
43. Extracellular signal-regulated kinase 1/2-mediated phosphorylation of JunD and FosB is required for okadaic acid-induced activator protein 1 activation [In Process Citation]
44. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
45. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?
46. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis
47. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice
48. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects
49. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis
50. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice